| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.66B | 117.31B | 143.17B | 145.77B | 142.58B | 144.14B |
| Gross Profit | 39.15B | 30.39B | 38.10B | 36.07B | 35.98B | 43.91B |
| EBITDA | 12.53B | 10.64B | 11.19B | 5.67B | 6.77B | 15.08B |
| Net Income | 7.51B | 8.07B | 6.01B | 3.01B | 3.06B | 9.35B |
Balance Sheet | ||||||
| Total Assets | 70.25B | 71.44B | 76.79B | 95.94B | 93.41B | 95.80B |
| Cash, Cash Equivalents and Short-Term Investments | 25.44B | 27.21B | 31.61B | 29.96B | 20.51B | 28.52B |
| Total Debt | 1.50B | 1.55B | 0.00 | 0.00 | 99.00M | 960.00M |
| Total Liabilities | 28.87B | 28.44B | 31.75B | 32.01B | 30.94B | 32.67B |
| Stockholders Equity | 41.38B | 43.00B | 45.04B | 63.92B | 62.46B | 63.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.49B | 13.57B | 4.57B | -1.47B | -245.00M |
| Operating Cash Flow | 0.00 | 3.70B | 14.72B | 6.63B | 392.00M | 1.00B |
| Investing Cash Flow | 0.00 | 631.00M | -1.36B | 5.37B | 2.74B | -1.84B |
| Financing Cash Flow | 0.00 | -8.79B | -7.16B | -2.61B | -4.51B | -6.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥151.07B | 6.16 | 12.77% | 2.84% | 11.98% | 115.65% | |
70 Outperform | ¥57.57B | 7.43 | ― | 2.03% | -18.06% | 64.88% | |
65 Neutral | ¥214.52B | 14.94 | ― | 2.70% | 8.28% | 7.21% | |
64 Neutral | ¥786.24B | -8.91 | 6.07% | 3.69% | 3.69% | -66.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥4.03T | 19.73 | ― | 3.27% | 1.75% | 93.78% | |
53 Neutral | ¥169.78B | -61.67 | -6.21% | 1.61% | -1.34% | -107.63% |